BioWorld: The Daily Biopharmaceutical and Medical Technology …
WEBBioWorld covers the latest developments and trends in biopharmaceutical and medical technology sectors worldwide. Find news, insights and opinions on drugs, devices, diagnostics, biomarkers and more.
‘Not a slowdown, a reversal’: Truebinding tackling ... - BioWorld
WEBMar 17, 2023 · It’s that aggregation that seven-year-old Truebinding Inc. aims to target with its lead program, TB-006, a monoclonal antibody against galectin-3. BioWorld Newco news. Cumulus raising $50M, spinning GPR68 small molecules into GIO. Cumulus Oncology Ltd. is in the thick of raising a $50 million series A round as its model of sourcing novel drug ...
BioWorld MedTech: The Daily Medical Technology News Source
WEBBioWorld Premium. Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription. Daily news and analysis of the medical technology industry. In-depth coverage of business, financing, regulation, science, innovation, device approvals, clinical trials and more.
Cumulus Oncology licenses small molecules from GPR68 drug
WEBAug 20, 2024 · Cumulus Oncology Ltd. has announced key milestones, in partnership with collaborator Leadxpro AG, in the companies’ protein structure-driven GPR68 drug discovery project. The partners announced their collaboration in July last year to develop small molecules against GPR68.
| BioWorld
WEBNov 16, 1994 · BioWorld MedTech. Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation, business, financing, regulation, science, product …
China - BioWorld
WEB3 days ago · BioWorld covers the latest developments in the biotechnology, pharmaceutical, medical device and medical technology sectors in China. Find out about clinical trials, approvals, deals, innovations and more from China's biotech industry.
CCM Biosciences outlines preclinical pipeline on launch
WEBAug 30, 2023 · CCM Biosciences outlines preclinical pipeline on launch. Aug. 30, 2023. CCM Biosciences Inc. has launched with a focus on discovering and developing novel drugs, including small molecules, gene therapies, biologics and nanomedicines, and companion diagnostic tests. BioWorld Science Newco news Drug design, drug delivery and technologies Cancer ...
Cresilon Traumagel wins FDA greenlight | BioWorld
WEBAug 21, 2024 · Cresilon Inc. announced that Traumagel, a hydrogel that stops bleeding in seconds, received U.S. FDA clearance. Traumagel is designed for use by the U.S. military, first responders and medical professionals to treat traumatic wounds.
US lawmakers flag clinical trials with ties to China military
WEBAug 21, 2024 · Drug and device sponsors conducting clinical trials in China to support U.S. FDA approval may want to reconsider their choice of trial sites, as trials conducted at hospitals and clinics affiliated with China’s military or in the Xinjiang Uyghur Autonomous Region could be in for increased scrutiny.
Dupixent atopic of talk as Galderma’s Nemluvio cleared in PN
WEBAug 13, 2024 · Aiming to offer an advantage over Dupixent (dupilumab, Regeneron Pharmaceuticals Inc.), dermatology-focused Galderma Holding SA won clearance from the U.S. FDA for Nemluvio (nemolizumab) as a prefilled pen providing a subcutaneous injection to treat adults with prurigo nodularis (PN). Cumulus Oncology Ltd. is …